The rats were given daily injections of tesofensine plus a fixed dose of 5-HTP (31 mg/kg, i.p.) and CB (75 mg/kg, i.p.) for 15 days, following one of six protocols: vehicle (control, n = 6 for each group), 5-HTP/CB (31 and 75 mg/kg), tesofensine1 (1 mg/kg, s.c.), tesofensine2 (2 mg/kg, s.c.), tesofensine1 + 5-HTP/CB, and tesofensine2 + 5-HTP/CB
Scientists continue to explore tissue biology and cellular signaling regarding this peptide
[DOI] [PMC free article] [PubMed] [Google Scholar] 475
BPC-157 Peptide may be a suitable treatment for moderate chronic joint pain , tendon injuries, and other ailments, but it is best not to go it alone
It doesn't mean BPC-157 is proven unsafe, but you shouldn't assume it's safe either
NaBPC157 positively effects both of them